Gildan Activewear Inc (GIL) concluded trading on Thursday at a closing price of $41.13, with 0.49 million shares of worth about $20.1 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -13.47% during that period and on April 17, 2025 the price saw a gain of about 1.16%. Currently the company’s common shares owned by public are about 152.41M shares, out of which, 149.74M shares are available for trading.
Stock saw a price change of 2.36% in past 5 days and over the past one month there was a price change of -12.10%. Year-to-date (YTD), GIL shares are showing a performance of -12.58% which increased to 14.35% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $32.23 but also hit the highest price of $55.39 during that period. The average intraday trading volume for Gildan Activewear Inc shares is 663.49K. The stock is currently trading -3.27% below its 20-day simple moving average (SMA20), while that difference is down -13.32% for SMA50 and it goes to -11.27% lower than SMA200.
Gildan Activewear Inc (NYSE: GIL) currently have 152.41M outstanding shares and institutions hold larger chunk of about 73.66% of that.
The stock has a current market capitalization of $6.24B and its 3Y-monthly beta is at 1.22. PE ratio of stock for trailing 12 months is 16.54, while it has posted earnings per share of $2.49 in the same period. Its PEG reads 1.64 and has Quick Ratio of 0.89 while making debt-to-equity ratio of 1.13. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GIL, volatility over the week remained 3.29% while standing at 3.79% over the month.
Stock’s fiscal year EPS is expected to rise by 15.68% while it is estimated to increase by 11.41% in next year. EPS is likely to shrink at an annualized rate of 10.10% for next 5-years, compared to annual growth of 14.09% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by UBS on January 10, 2025 offering a Buy rating for the stock and assigned a target price range of between $50 and $60 to it. Stock get a Buy rating from TD Securities on August 04, 2023.
